Halozyme Therapeutics, Inc. (HALO) Stock Price & News

Symbols Symbols	Price	Change	% Change	Trend	Prev Close	Open	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB +0.25%	1,104.10	+2.73	+0.25%	—	1,101.37	1,103.63	1,105.31	1,091.41	—	—
SIXC Communications SIXC Communications	SIXC -1.50%	604.16	-9.19	-1.50%	—	613.35	613.35	613.35	601.49	—	—
SIXE Energy SIXE Energy	SIXE -0.09%	1,197.81	-1.02	-0.09%	—	1,198.83	1,199.68	1,199.75	1,182.41	—	—
SIXI Industrials SIXI Industrials	SIXI -0.88%	1,740.41	-15.54	-0.88%	—	1,755.95	1,754.06	1,756.03	1,734.69	—	—
SIXM Financials SIXM Financials	SIXM -0.64%	634.44	-4.07	-0.64%	—	638.51	637.41	637.41	633.05	—	—
SIXR Staples SIXR Staples	SIXR -0.31%	840.90	-2.62	-0.31%	—	843.52	843.35	846.40	837.93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0.38%	215.13	-0.82	-0.38%	—	215.95	215.95	216.84	215.06	—	—
SIXT Technology SIXT Technology	SIXT +2.86%	3,228.71	+89.80	+2.86%	—	3,138.91	3,189.30	3,230.85	3,174.76	—	—
SIXU Utilities SIXU Utilities	SIXU +0.16%	935.87	+1.50	+0.16%	—	934.37	934.72	938.26	927.50	—	—
SIXV Health care SIXV Health care	SIXV -1.37%	1,457.12	-20.31	-1.37%	—	1,477.43	1,474.12	1,474.12	1,451.80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0.83%	2,399.84	+19.65	+0.83%	—	2,380.19	2,389.34	2,403.04	2,380.47	—	—

HALO:NASDAQ

Halozyme Therapeutics, Inc.

$65.36

-1.85%

(-1.23) 1D

$65.36

0.00% (0.00)

After hours

Closed: Apr 24, 4:00:01 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for HALO...

Open

$66.31

High

$66.47

Low

$64.80

Mkt. cap

7.74B

Avg. vol.

1.46M

Volume

1.40M

P/E ratio

25.56

52-wk high

$82.22

52-wk low

$47.50

EPS

$2.56

Beta

1.03

Shares outstanding

118.47M

No. of employees

423

Related stocks

Vertex Pharmaceuticals Inc

Bristol-Myers Squibb Co

$58.71

-0.53%

News stories

From sources across the web

Simply Wall Street

1 hour ago

Is Kaltura’s (KLTR) Region-Specific AI Push Quietly Reframing Its Global Enterprise Risk-Reward Profile?

TechnoTrenz

1 hour ago

Dow Q1 2026 Earnings: Revenue Hits $9.8B

MSN

1 hour ago

The Nasdaq is on fire. Here are the 2 best artificial intelligence (AI) growth stocks that still look cheap

MarketBeat

2 hours ago

Prairie Operating Co. (NASDAQ:PROP) Short Interest Up 102.8% in April

Profile

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia

About Halozyme Therapeutics, Inc.

CEOHelen I. Torley

Employees423

Founded1998

HeadquartersSan Diego, California, United States

SectorBiotechnology

Websitehalozyme.com

All values in USD	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	264.86M	325.72M	354.26M	451.77M
Cost of goods sold	63.20M	46.36M	72.49M	110.67M
Cost of revenue	63.20M	46.36M	72.49M	110.67M
Research and development expenses	-	17.54M	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	42.36M	41.61M	46.09M	63.33M
Operating expense	60.12M	76.92M	63.85M	86.70M
Total operating expenses	123.33M	123.28M	136.34M	197.37M
Operating income	141.54M	202.44M	217.92M	254.40M
Other non operating income	-	6.89M	-	-
EBT including unusual items	143.83M	204.94M	218.96M	-100.85M
EBT excluding unusual items	142.12M	204.94M	218.96M	251.58M
Income tax expense	25.73M	39.78M	43.73M	40.74M
Effective tax rate	17.89%	19.41%	19.97%	-40.40%
Other operating expenses	-	-	-	-
Net income	118.10M	165.16M	175.22M	-141.59M
Net profit margin	44.59%	50.71%	49.46%	-31.34%
Earnings per share	1.11	1.54	1.72	-0.24
Interest and investment income	5.11M	-	5.33M	2.09M
Interest expense	-4.52M	-4.39M	-4.30M	-4.91M
Net interest expenses	584.00K	-4.39M	1.04M	-2.82M
Depreciation and amortization charges	-	-	-	-
EBITDA	160.48M	221.44M	236.84M	279.08M
Gain or loss from assets sale	-	-	-	2.62M

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research